Tindle R - Search Results

1

Provision of 4-1BB ligand enhances effector and memory CTL responses generated by immunization with dendritic cells expressing a human tumor-associated antigen.

Wiethe C, Dittmar K, Doan T, Lindenmaier W, Tindle R. Wiethe C, et al. Among authors: tindle r. J Immunol. 2003 Mar 15;170(6):2912-22. doi: 10.4049/jimmunol.170.6.2912. J Immunol. 2003. PMID: 12626542

2

Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen.

Wiethe C, Dittmar K, Doan T, Lindenmaier W, Tindle R. Wiethe C, et al. Among authors: tindle r. J Immunol. 2003 Oct 15;171(8):4121-30. doi: 10.4049/jimmunol.171.8.4121. J Immunol. 2003. PMID: 14530334

3

Limitations of HLA-transgenic mice in presentation of HLA-restricted cytotoxic T-cell epitopes from endogenously processed human papillomavirus type 16 E7 protein.

Street MD, Doan T, Herd KA, Tindle RW. Street MD, et al. Immunology. 2002 Aug;106(4):526-36. doi: 10.1046/j.1365-2567.2002.01442.x. Immunology. 2002. PMID: 12153516 Free PMC article.

4

Co-immunisation with DNA encoding RANK/RANKL or 4-1BBL costimulatory molecules does not enhance effector or memory CTL responses afforded by immunisation with a tumour antigen-encoding DNA vaccine.

Herd KA, Wiethe C, Tindle RW. Herd KA, et al. Vaccine. 2007 Jul 9;25(28):5209-19. doi: 10.1016/j.vaccine.2007.04.083. Epub 2007 May 21. Vaccine. 2007. PMID: 17544551

5

A polytope DNA vaccine elicits multiple effector and memory CTL responses and protects against human papillomavirus 16 E7-expressing tumour.

Doan T, Herd K, Ramshaw I, Thomson S, Tindle RW. Doan T, et al. Cancer Immunol Immunother. 2005 Feb;54(2):157-71. doi: 10.1007/s00262-004-0544-6. Epub 2004 Oct 7. Cancer Immunol Immunother. 2005. PMID: 15480657 Free PMC article.

6

Hepatitis B surface antigen vector delivers protective cytotoxic T-lymphocyte responses to disease-relevant foreign epitopes.

Woo WP, Doan T, Herd KA, Netter HJ, Tindle RW. Woo WP, et al. J Virol. 2006 Apr;80(8):3975-84. doi: 10.1128/JVI.80.8.3975-3984.2006. J Virol. 2006. PMID: 16571814 Free PMC article.

7

Differences in the effectiveness of delivery of B- and CTL-epitopes incorporated into the hepatitis B core antigen (HBcAg) c/e1-region.

Street M, Herd K, Londono P, Doan T, Dougan G, Kast WM, Tindle RW. Street M, et al. Among authors: tindle rw. Arch Virol. 1999;144(7):1323-43. doi: 10.1007/s007050050590. Arch Virol. 1999. PMID: 10481740

8

Nonspecific down-regulation of CD8+ T-cell responses in mice expressing human papillomavirus type 16 E7 oncoprotein from the keratin-14 promoter.

Tindle RW, Herd K, Doan T, Bryson G, Leggatt GR, Lambert P, Frazer IH, Street M. Tindle RW, et al. J Virol. 2001 Jul;75(13):5985-97. doi: 10.1128/JVI.75.13.5985-5997.2001. J Virol. 2001. PMID: 11390600 Free PMC article.

9

Peripheral tolerance to human papillomavirus E7 oncoprotein occurs by cross-tolerization, is largely Th-2-independent, and is broken by dendritic cell immunization.

Doan T, Herd KA, Lambert PF, Fernando GJ, Street MD, Tindle RW. Doan T, et al. Among authors: tindle rw. Cancer Res. 2000 Jun 1;60(11):2810-5. Cancer Res. 2000. PMID: 10850419

10

Mice expressing the E7 oncogene of HPV16 in epithelium show central tolerance, and evidence of peripheral anergising tolerance, to E7-encoded cytotoxic T-lymphocyte epitopes.

Doan T, Chambers M, Street M, Fernando GJ, Herd K, Lambert P, Tindle R. Doan T, et al. Among authors: tindle r. Virology. 1998 May 10;244(2):352-64. doi: 10.1006/viro.1998.9128. Virology. 1998. PMID: 9601506 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters